Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Imugene Ltd
(OP:
IUGNF
)
0.1741
-0.0059 (-3.28%)
Streaming Delayed Price
Updated: 11:34 AM EST, Feb 6, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
8,120
Open
0.1741
Bid (Size)
N/A (0)
Ask (Size)
N/A (0)
Prev. Close
0.1800
Today's Range
0.1741 - 0.2115
52wk Range
0.0018 - 0.3048
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Imugene to commence new phase 2 PD1-Vaxx bowel cancer trial
December 06, 2023
Imugene Ltd (ASX:IMU, OTC:IUGNF) CEO Leslie Chong tells Proactive the company is preparing 10 clinical trial sites in Australia and the UK for a new PD1-Vaxx Phase 2 colorectal (CRC) cancer clinical...
Via
TheNewswire.com
Imugene to commence new phase 2 PD1-Vaxx bowel cancer trial
December 06, 2023
--News Direct--
Via
News Direct
Performance
YTD
-35.5%
-35.5%
1 Month
-9.0%
-9.0%
3 Month
-13.0%
-13.0%
6 Month
+0.3%
+0.3%
1 Year
+599.2%
+599.2%
More News
Read More
Imugene thrilled as VAXINIA granted FDA Fast Track designation
November 28, 2023
Via
TheNewswire.com
Imugene thrilled as VAXINIA granted FDA Fast Track designation
November 28, 2023
Via
News Direct
Imugene thrilled as first patient dosed in Phase 1 OASIS trial
October 26, 2023
Via
TheNewswire.com
Imugene thrilled as first patient dosed in Phase 1 OASIS trial
October 26, 2023
Via
News Direct
Imugene talks VAXINIA MAST trial and corporate ambition
September 04, 2023
Via
News Direct
Imugene talks VAXINIA MAST trial and corporate ambition
September 04, 2023
Via
TheNewswire.com
Imugene off to strong start to 2023 with JP Morgan Healthcare Conference
January 23, 2023
Via
TheNewswire.com
Imugene off to strong start to 2023 with JP Morgan Healthcare Conference
January 23, 2023
Via
News Direct
Frequently Asked Questions
Is Imugene Ltd publicly traded?
Yes, Imugene Ltd is publicly traded.
What exchange does Imugene Ltd trade on?
Imugene Ltd trades on the OTC Traded
What is the ticker symbol for Imugene Ltd?
The ticker symbol for Imugene Ltd is IUGNF on the OTC Traded
What is the current price of Imugene Ltd?
The current price of Imugene Ltd is 0.1741
When was Imugene Ltd last traded?
The last trade of Imugene Ltd was at 02/06/26 11:34 AM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today